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patients: a step closer to primary prevention trialsOsteoarthritis (OA) is the leading cause of disability and knee
OA alone affects over 250 million people worldwide1. Obesity is a
major risk factor for knee OA and a 10% weight loss combined
with exercise is a safe, effective treatment2.
However, little is known about the effect of long term weight
gain on incident knee OA. In the ﬁrst study on the question, Buck-
nor and colleagues3 used the Osteoarthritis Initiative (OAI) data-
base to examine the association of weight gain over a 4-year
period with early morphologic abnormalities using the modiﬁed
whole organMRI score (WORMS). Older (mean age¼ 58 yrs) adults
whose BMI consistently increased over 4 years (mean weight
gain ¼ 15%; minimum ¼ 5%) were compared to age, gender, and
baseline BMI matched counterparts who maintained their body
weight without ﬂuctuations > 2% (mean weight gain ¼ 0.04%)
over the same period. The mean (Standard Deviation) baseline
BMIs were 28.1 kg/m2 (5.3) and 28.7 kg/m2 (4.8) for the two groups,
respectively. Both groups were asymptomatic at baseline with at
least one risk factor (overweight or obese, knee symptoms in the
past 12months, history of knee injury, history of knee surgery, fam-
ily history of knee replacement, or Heberden nodes). Symptomatic
was deﬁned as frequent symptoms and radiographic OA in the
same knee. The number of eligible subjects in the OAI incidence
cohort that met the inclusion criteria for the weight gain group
was 520, of which 50 were randomly selected and matched with
50 of a possible 808 eligible subjects in the no weight gain group.
Statistical analyses were adjusted for baseline BMI, average 5
year activity level, and three-level KellgreneLawrence (KeL) score
(0e1, 2, 3e4). The odds of incident knee OA (i.e., development of
new cases of knee OA) at 4 year follow-up were signiﬁcantly higher
for the weight gain group than for those that did not gain weight.
Using MRI, the weight gain group was 11 times more likely to
have maximum cartilage lesions (i.e., a lesion was deﬁned as any
cartilage abnormality WORMS grade 1 on a 0e6 scale with
0 ¼ normal and 6 ¼ diffuse full-thickness loss; maximum lesion
was deﬁned as the greatest WORMS score in any compartment)
and 4.5 times more likely to be progressing toward greater
maximum meniscus lesions (i.e., a meniscus lesion was deﬁned as
any abnormality WORMS grade  1 on a 0e4 scale with
0 ¼ normal and 4 ¼ complete destruction and maceration of the
meniscus). Further, the odds of having progression of patella carti-
lage lesions, average meniscal lesions (i.e., average score across six
regions), and average bone marrow edema patterns (i.e., averageDOI of original article: http://dx.doi.org/10.1016/j.joca.2014.10.013.
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1063-4584/© 2015 Osteoarthritis Research Society International. Published by Elsevier Lscore across six anatomical compartments using a modiﬁed
WORMS) were signiﬁcantly higher for the weight gain group.
Ordinarily, physicians and other health care professionals do
not recommend that their overweight patients gain more weight.
So why is this study important? First, it underscores the impor-
tance, in the absence of signiﬁcant weight loss, of maintaining
body weight, even in overweight adults. Those with risk factors
for knee OA at baseline who steadily gain weight over time will
progress to incident knee OA more often than similar adults who
do not gain weight; the weight gain group was three times more
likely to showMRI signs of progression. Second, the study provides
important information about the characteristics of a cohort that is
likely to progress to incident knee OA and the length of the obser-
vation period necessary to detect early signs of progression. Finally,
while long term obesity increases the risk of knee OA4, this study
suggests that weight gain later in life is also an important risk
factor.
With the projected lifetime risk of symptomatic knee OA as high
as 45%5, primary prevention trials are urgently needed. The main
barrier is the typical funding period; efforts to predict who will
progress to incident knee OA within its limits would yield few
detectable structural changes, resulting in poor statistical power.
For example, in a general population of women aged 45e64 years,
the annual incidence rate of progression from knees with KeL
scores of 0 or 1 to KeL scores 2 was less than 3%6. In the Bucknor
study, approximately 50% of the weight gain group showed at least
one MRI sign of incident disease after 4 years compared to the 17%
incident rate in the no weight gain group. However, its 4-year
observation period is more than twice the duration of interven-
tions in previous secondary OA prevention trials2,7e9, and a 50%
progression rate also implies that half the incident cohort will
not progress sufﬁciently during that interval. Hence, being able
to recruit an enriched cohort with risk factors for knee OA that
will show signiﬁcant progression in a reasonable time period is
critical if primary prevention trials with structural outcomes are
to succeed. Moreover, predicting who will gain weight is problem-
atic. In addition to the criteria used by Bucknor et al., limiting the
cohort to post-menopausal women might increase the likelihood
of weight gain.
It is important to note some limitations in this study. Including a
larger sample of the eligible incidence cohort (less than 10% were
used in this study) would have increased the statistical power
and possibly strengthened group differences. At present there is
an MRI deﬁnition of OA but this deserves further validation. As
OA is a clinical disease the impact these MRI structural changestd. All rights reserved.
Editorial / Osteoarthritis and Cartilage 23 (2015) 501e502502have on incident disease (i.e., with symptoms) warrants further ex-
amination. Finally, this is an observational study, therefore it cannot
truly deﬁne cause and effect. The authors were prudent in control-
ling for activity level and baseline KeL score as this reduced the
likelihood that persons who developed more structural changes
either became more immobile and gained weight or had more
structural change at baseline than the comparison group.
Determining the best biomarkers to predict disease incidence
and progression early is critical in formulating potentially high-
impact randomized clinical trials. Bucknor et al. show the value of
the OAI in providing important new information on disease pro-
gression that should be considered in designing future primary pre-
vention trials.
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